1887

Journal of General Virology header logo

Volume 63, Issue 2

Characterization of Non-oncogenic Marek's Disease Virus-infected and Turkey Herpesvirus-infected Lymphocytes Free

Abstract

Summary

Splenic leukocytes derived from N- and P-line chickens exposed to turkey herpesvirus (HVT-4), and from UCD-003 chickens exposed to the non-oncogenic SB-1 clone of Marek's disease virus were fractionated into subpopulations at various days post-exposure. The level of infection in these fractions was determined by enumeration of plaque-forming units after co-cultivation of leukocytes with virus-permissive chicken embryo fibroblasts. At 5 days post-exposure most HVT-4-infected lymphocytes were found to be of intermediate to low buoyant density (1.040 to 1.065 g/ml) and not to have detectable Fc receptors. They possessed surface Ia but were not IgM-bearing. At 15 days post-exposure HVT-4-infected lymphocytes were found to be of intermediate to high buoyant density (1.070 to 1.080 g/ml) and, at this time, virus isolation rates (p.f.u./10 cells) from fractions enriched in cells bearing Fc receptors were approximately equal to those leukocyte suspensions depleted of Fc receptor-bearing cells. Furthermore, the percentage reduction in infectivity caused by depletion of Ia-bearing cells at 15 days post-exposure was less than that at 5 days post-exposure. At both 5 and 15 days post-exposure carbonyl iron treatment failed to remove HVT-4-infected lymphocytes. These characteristics were similar whether HVT-4-infected lymphocytes were derived from N- or P-line chickens. SB-1-infected lymphocytes derived from UCD-003 chickens at 6, 7 and 14 days post-exposure were detected with equal frequency in fractions enriched or depleted of cells possessing Fc receptors. SB-1-infected lymphocytes for the most part lacked surface Ia and IgM, and were not depleted by carbonyl iron treatment. From these data it was concluded that most HVT-4- and SB-1-infected lymphocytes detectable by virus isolation were neither B cells nor macrophages.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): lymphocytes , MDV and turkey herpesvirus
© Society for General Microbiology, 1982
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-63-2-333
1982-12-01
2024-12-04
Loading full text...

Full text loading...

/deliver/fulltext/jgv/63/2/JV0630020333.html?itemId=/content/journal/jgv/10.1099/0022-1317-63-2-333&mimeType=html&fmt=ahah

References

  1. Biggs P. M., Milne B. S. 1972; Biological properties of a number of Marek’s disease virus isolates. In Oncogenesis and Herpesviruses pp. 88–94 Edited by Biggs P. M., De The G., Payne L. N. Lyon: IARC Scientific Publications;
     [Google Scholar]
  2. Von Bülow V., Biggs P. M. 1975; Precipitating antigens associated with Marek’s disease viruses and a herpesvirus of turkeys. Avian Pathology4147–162
     [Google Scholar]
  3. Von Bülow V., Biggs P. M., Frazier J. A. 1975; Characterization of a new serotype of Marek’s disease herpesvirus. In Oncogenesis and Herpesviruses II part 2 pp. 329–336 Edited by de The G., Epstein M. A., Zur Hausen H. Lyori: IARC Scientific Publications;
     [Google Scholar]
  4. Calnek B. W. 1973; Influence of age at exposure on the pathogenesis of Marek’s disease. Journal of the National Cancer Institute 51:929–939
     [Google Scholar]
  5. Calnek B. W., Fabricant J., Schat K. A., Murthy K. K. 1977; Pathogenicity of low-virulence Marek’s disease viruses in normal versus immunologically compromised chickens. Avian Diseases 21:346–358
     [Google Scholar]
  6. Calnek B. W., Carlisle J. C., Fabricant J., Murthy K. K., Schat K. A. 1979; Comparative pathogenesis studies with oncogenic and nononcogenic Marek’s disease viruses and turkey herpesvirus. American Journal of Veterinary Research 40:541–548
     [Google Scholar]
  7. Calnek B. W., Schat K. A., Fabricant J. 1980; Modification of Marek’s disease pathogenesis by in ovo infection or prior vaccination. In Viruses in Naturally Ocurring Cancers pp. 185–197 Edited by Essex M., Todaro G., Zur Hausen H. New York: Cold Spring Harbor Laboratory;
     [Google Scholar]
  8. Calnek B. W., Shek W. R., Schat K. A. 1981a; Latent infections with Marek’s disease virus and turkey herpesvirus. Journal of the National Cancer Institute 66585–590
     [Google Scholar]
  9. Calnek B. W., Shek W. R., Schat K. A. 1981b; Spontaneous and induced herpesvirus genome expression in Marek’s disease tumor cell lines. Infection and Immunity 34:483–486
     [Google Scholar]
  10. Calnek B. W., Shek W. R., Schat K. A., Fabricant J. 1982a; Dose-dependent inhibition of virus rescue from lymphocytes latently infected with turkey herpesvirus or Marek’s disease virus. Avian Diseases 26:321–331
     [Google Scholar]
  11. Calnek B. W., Schat K. A., Shek W. R., Chen H. 1982b; In vitro infection of lymphocytes with Marek’s disease virus. Journal of the National Cancer Institute (in press)
    [Google Scholar]
  12. Cho B. R. 1976; A possible association between plaque type and pathogenicity of Marek’s disease herpesvirus. Avian Diseases 20:324–331
     [Google Scholar]
  13. Cho B. R. 1977; Studies of turkey herpesviremia in two strains of vaccinated chickens: strain difference and effects of vaccine dose. Avian Diseases 21:394–401
     [Google Scholar]
  14. Churchill A. E., Payne L. N., Chubb R. C. 1969; Immunization against Marek’s disease using live attenuated virus. Nature, London 221:744–747
     [Google Scholar]
  15. Dorvall G., Bourka A. E., Menezes J. 1979; Comparative studies on the expression of Fc receptors, Ia antigens and B2 microglobulin following in vitro herpes simplex virus infection of human lymphoid cells. Clinical and Experimental Immunology 37:477–485
     [Google Scholar]
  16. Ewert D. L., Cooper M. D. 1978; Ia-like alloantigens in the chicken: serologic characterization and ontogeny of cellular expression. Immunogenetics 7:521–535
     [Google Scholar]
  17. Fabricant J., Calnek B. W., Schat K. A. 1982; The early pathogenesis of turkey herpesvirus infection in chickens and turkeys. Avian Diseases 26:257–264
     [Google Scholar]
  18. Hirai K., Ikuta K., Kitamoto N., Kato S. 1981; Latency of herpesvirus of turkey and Marek’s disease virus genomes in a chicken T-lymphoblastoid cell line. Journal of General Virology 53:133–143
     [Google Scholar]
  19. Ivanyi J., Hudson L. 1979; Allelic exclusion of M1 (IgM) allotype on the surface of chicken B cells. Immunology 35:941–945
     [Google Scholar]
  20. Kedar E., Ortiz De Landazuri M., Bonavida B. 1974; Cellular immunoadsorbents: a simplified technique for separation of lymphoid cell populations. Journal of Immunology 112:1231–1243
     [Google Scholar]
  21. Para M. F., Baucke R. B., Spear P. G. 1980; Immunoglobulin G (Fc) binding receptor on virions of herpes simplex virus type 1 and transfer of these receptors to the cell surface by infection. Journal of Virology 34:512–520
     [Google Scholar]
  22. Parish C. R., Kirov S. M., Bowern N., Blanders R. V. 1974; A one step procedure for separating mouse T and B lymphocytes. European Journal of Immunology 4:808–815
     [Google Scholar]
  23. Purchase H. G., Burmester B. R., Cunningham C. H. 1971a; Pathogenicity and antigenicity of clones from strains of Marek’s disease virus and the herpesvirus of turkeys. Infection and Immunity 3:295–303
     [Google Scholar]
  24. Purchase H. G., Witter R. L., Okazaki W., Burmester B. R. 1971b; Vaccination against Marek’s disease. Perspectives in Virology 7:91–110
     [Google Scholar]
  25. Rispens B. H., Van Vloten H., Mastenbroek N., Maas H. J. L., Schat K. A. 1972; Control of Marek’s disease in the Netherlands. I. Isolation of an avirulent Marek’s disease virus (strain CV1988) and its use in laboratory vaccination trials. Avion Diseases 16:108–125
     [Google Scholar]
  26. Schat K. A., Calnek B. W. 1978; Characterization of an apparently nononcogenic Marek’s disease virus. Journal of the National Cancer Institute 60:1075–1081
     [Google Scholar]
  27. Schat K. A., Calnek B. W., Fabricant J. 1981a; Influence of bursa of Fabricius on the pathogenesis of Marek’s disease. Infection and Immunity 31:199–207
     [Google Scholar]
  28. Schat K. A., Calnek B. W., Fabricant J., Abplanalp H. 1981b; Influence of oncogenicity of Marek’s disease on evaluation of genetic resistance. Poultry Science 60:2559–2566
     [Google Scholar]
  29. Schat K. A., Chen C.-L. H., Shek W. R., Calnek B. W. 1982; Surface antigens on Marek’s disease l ymphoblastoid cell lines. Journal of the National Cancer Institute (in press)
    [Google Scholar]
  30. Shek W. R. 1982 Characterization of chicken lymphocytes infected with Marek’s disease virus or turkey herpesvirus Ph.D. thesis Cornell University;
     [Google Scholar]
  31. Smith M. W., Calnek B. W. 1974; Comparative features of low-virulence and high-virulence Marek’s disease virus. Avian Pathology 3:229–246
     [Google Scholar]
  32. Wardley R. C., Rouse B. T., Babiuk L. A. 1976; Lymphocyte activation by cell separation procedures. Immunological Communications 5:637–648
     [Google Scholar]
  33. Witter R. L., Nazerian K., Purchase H. G., Burgoyne G. H. 1970; Isolation from turkeys of a cell associated herpesvirus antigenically related to Marek’s disease virus. American Journal of Veterinary Research 31:525–538
     [Google Scholar]
  34. Witter R. L., Sharma J. M., Offenbecker L. 1976; Turkey herpesvirus infection in chickens: induction of lymphoproliferative lesion and characterization of viral immunity against Marek’s disease. Avian Diseases 20:676–692
     [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-63-2-333
Loading
Characterization of Non-oncogenic Marek's Disease Virus-infected and Turkey Herpesvirus-infected Lymphocytes
J. Gen. Virol. 63, 333 (1982); https://doi.org/10.1099/0022-1317-63-2-333
/content/journal/jgv/10.1099/0022-1317-63-2-333
/content/journal/jgv/10.1099/0022-1317-63-2-333
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error